FLGT (Fulgent Corp) Rasio Nilai Pasar marang Nilai Buku

Fulgent Genetics, Inc. (FLGT) revenues rely on commercial software for clinics and genetic testing volumes, while its liquidity reserve offsets the decline in revenue from COVID-19 testing. The business synthesizes medical laboratory precision with IT sector dynamics, attracting experts through innovation. The price trend, which stands at 0.57, illustrates a company developing high-throughput DNA analysis and oncology diagnostics while retaining staff through stock options and technological growth.

FLGT - Koefisien Nilai Pasar marang Nilai Buku Fulgent ing rentang 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar Fulgent Genetics Inc (FLGT)

- rega lan prakiraan konsensus rega:

Kutipan saham Fulgent Genetics, Inc.|FLGT - Rega prakiraan analis

- data kapitalisasi pasar:

Nilai pasar Fulgent Corp|FLGT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Fulgent Genetics|FLGT - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku fulgentgenetics.com|FLGT - Total Aset Bisnis

- data utang lan likuiditas:

Total Utang marang Modal Fulgent Genetics, Inc.|FLGT - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Fulgent Corp|FLGT - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Fulgent Corp

Analisis wiwitan perusahaan:Fulgent Genetics, Inc. - FLGT

Investments in the robotic sequencing laboratories of Fulgent Genetics, Inc. (FLGT) require an assessment of technological asset values relative to market price. This chart of market capitalization to net book assets compares current capitalization with book value, making it possible to distinguish temporary undervaluation from systemic business degradation. A low ratio signals the risk of a "value trap," where the market price fails to account for actual depreciation or the inflationary revaluation of equipment.

Pesaing langsung